MedCity and Stroke Association have entered into a collaboration agreement to identify and support the development of digital health therapeutics and medical devices for patients and carers living with the long-term health impact of stroke.

Stroke Association will provide funding and expertise, while MedCity will bring its extensive experience promoting the transfer of knowledge between academia and industry. A total funding pot of £180,000 will be available, with awards made through the programme being directed to innovations that:

  1. lead to measurable improvement in patient recovery and quality of life
  2. reduce the risks of follow on stroke
  3. provide support to carers of stroke patients.

Applications will be invited from companies developing digital health and medical device innovations across a broad development pathway, with an expectation that support will be provided for the development of technologies from a proof of concept stage, through and up to the commercialisation/implementation stage.

Read full Stroke Association article.

Back to e-newsletter